Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
Radiother Oncol
; 164: 50-56, 2021 11.
Article
in En
| MEDLINE
| ID: mdl-34537289
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Radiotherapy, Intensity-Modulated
Type of study:
Guideline
Limits:
Female
/
Humans
Language:
En
Journal:
Radiother Oncol
Year:
2021
Document type:
Article
Affiliation country: